Value.Today
About World Top Companies Value

Top Companies Revenues and Profits

PFIZER INC
World Rank (Jan-2020):
37
Market Value (Jan 1st 2020):
215.483 Billion USD
World Rank (July-04-2020)
43
Market Cap (July-04-2020):
191.697 Billion USD
World Rank (Aug-22-2020):
34
Market Cap (Aug-22-2020)
216.051 Billion USD
Stock Category:
Headquarters of Company:
Head Quarters Region:
Company Products / Services:
Number of Employees:
88,300
Employee Count as on Date:
As on 2019
CEO:
Yahoo @ NYSE
Wikipedia
Twitter
Facebook
Bloomberg
Stock Exchange:
Company Website:
Founded Year:
1849
Business Sector:
Annual Revenue:
PFIZER Annual Revenues for 2019-DEC ending is 51.75 Billion USD
Annual Net Income:
PFIZER Annual Net Income for 2019-DEC ending is 16.27 Billion USD
Total Current Assets
PFIZER Total Current Assets as on June-2020 is 46,424 Million USD
Total Assets
PFIZER Total Assets as on June-2020 is 177,934 Million USD
Total Current Liabilities
PFIZER Total Current Liabilities as on June-2020 is 32,723 Million USD
Total Liabilities
PFIZER Total Liabilities as on June-2020 is 113,598 Million USD
About Company Business:

Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world.

Quarterly Results Summary:

Pfizer Inc - Quarterly Revenue and Net Profit - in Billion USD:

Quarter - Ending Revenue Net Profit EPS (USD)
Jun-2020 11.80 3.42 0.61
Mar-2020 12.03 3.40 0.61
Dec-2019 12.69 (-)0.33  (Loss) -0.06
Sep-2019 12.68 7.68 1.38
Jun-2019 13.26 5.05 0.88
Mar-2019 13.12 3.88 0.68  
Dec-2018 13.98 (-)0.39 (Loss)  -0.05
Sep-2018 13.30 4.11  0.68
Jun-2018 13.47 3.87  0.65
Annual Results Summary:

Pfizer Inc - Yearly Revenue and Net Profit - in Billion USD:

Year - Ending Revenue Net Profit EPS (USD)
Dec-2019 51.75 16.27 2.92
Dec-2018 53.65 11.15 1.90
Dec-2017 52.54 21.31 4.57
Dec-2016 52.82  7.21  1.18
Founders

Comments

Pfizer is expanding Phase 3 Trials to test Covid-19 Vaccine

Pfizer and BioNTech planning to expand phase 3 trials to test Covid-19 vaccine. From initial plan of 30,000 people, now they are planning to conduct trials of Covid-19 vaccine on 44,000 people. They are expecting results by Oct-2020 ending.

 

Sun, 13/09/2020 - 20:28

Share

© Copyright 2018-2020 | Value.Today | All rights reserved | eMail : info@value.today | Asia's best trusted site